437 results on '"Metastasis -- Care and treatment -- Patient outcomes"'
Search Results
2. Reports Summarize Cancer Research from Homi Bhabha National Institute (Geriatric Assessment-guided therapy modification and outcomes in patients with non-metastatic gastroesophageal cancer: a retrospective cohort study)
3. PD-1/PD-L1 Blockade Combined with AbnobaViscum Therapy is Linked to Improved Survival in Advanced or Metastatic NSCLC Patients, an ESMO-GROW Related Real-World Data Registry Study (Updated October 25, 2024)
4. PD-1/PD-L1 Blockade Combined with AbnobaViscum® Therapy is Linked to Improved Survival in Advanced or Metastatic NSCLC Patients, an ESMO-GROW Related Real-World Data Registry Study
5. BriaCell announces survival data from Phase 2 metastatic breast cancer study
6. Researcher at Mayo Clinic Releases New Data on Prostate Cancer [Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)]
7. Data on Gastric Cancer Detailed by Researchers at Department of Medical Oncology [Early Palliative Care and Overall Survival In Patients With Metastatic Upper Gastrointestinal Cancers (Epic): a Multicentre, Open-label, Randomised Controlled ...]
8. New Findings in Non-Small Cell Lung Cancer Described from University of Pennsylvania [Real-world Outcomes of Atypical Egfr- Mutated Metastatic Non-small Cell Lung Cancer (Mnsclc) Treated With Osimertinib (Osi) Vs. Afatinib or Erlotinib
9. Semmelweis University Researchers Describe New Findings in Endometrial Cancer [Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal ...]
10. IMFINZI[R] (durvalumab) perioperative regimen improved event-free survival and overall survival across muscle-invasive bladder cancer patients regardless of complete pathology response status in post-hoc exploratory analysis of NIAGARA Phase III trial
11. RYBREVANT (amivantamab-vmjw) plus LAZCLUZE(TM) (lazertinib) show statistically significant and clinically meaningful improvement in overall survival versus osimertinib
12. A novel weight optimized dynamic conformal arcs with TrueBeam™ Linac for very small tumors (≤1 cc) with single isocenter of multiple brain metastases (2≤, ≥4) in stereotactic radiosurgery: A comparison with volumetric modulated arc therapy
13. Studies from H. Lee Moffitt Cancer Center and Research Institute Further Understanding of Breast Cancer [Factors associated with overall survival in breast cancer patients with leptomeningeal disease (LMD): a single institutional retrospective ...]
14. Surgery Before Systemic Therapy Improves Outcomes in Metastatic RCC
15. Choroidal metastasis: Radiation and bevacizumab at presentation
16. Researchers at German Cancer Research Center (DKFZ) Target Colon Cancer (Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors)
17. New Carcinomas Findings Reported from University Hospital Essen (Clinical Outcomes By Baseline Metastases In Patients With Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab Versus Sunitinib: Post Hoc Analysis of the Clear Trial)
18. Investigators from Dana-Farber Cancer Institute Have Reported New Data on Urothelial Cancer (Real-world Treatment Patterns and Clinical Outcomes In Patients With Locally Advanced or Metastatic Urothelial Carcinoma By Eligibility for Maintenance ...)
19. BriaCell 2024 SABCS(r) Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer
20. ERLEADA(r) (apalutamide) demonstrates statistically significant and clinically meaningful improvement in overall survival compared to enzalutamide in patients with metastatic castration-sensitive prostate cancer
21. Survival after surgery for spinal metastases: a population-based study
22. Studies from University of Florida Describe New Findings in Brain Metastasis (The Safety and Efficacy of Concurrent Immune Checkpoint Blockade and Stereotactic Radiosurgery Therapy With Practitioner and Researcher Recommendations)
23. Studies from University of Toronto in the Area of Cancer Published (Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis)
24. Studies from University Hospital Zurich Further Understanding of Oncology (Stereotactic body radiotherapy for oligoprogression with or without switch of systemic therapy)
25. Research Results from Department of Otorhinolaryngology and Head and Neck Surgery Update Understanding of Squamous Cell Carcinoma (Parotid Gland Metastases of Cutaneous Squamous Cell Carcinoma of the Head: Occult Metastases Occurrence and Their ...)
26. Researcher at Brigham and Women's Hospital Targets Algorithms (Survival in Patients With Spinal Metastatic Disease Treated Nonoperatively With Radiotherapy)
27. Studies from Peking University First Hospital Further Understanding of Amputation (An elderly low-grade fibromyxoid sarcoma patient with early postoperative recurrences and metastases: a case report and literature review)
28. Researcher at University of Texas MD Anderson Cancer Center Discusses Research in Adenocarcinoma [Addition of metastasis-directed therapy to standard-of-care systemic therapy for oligometastatic pancreatic ductal adenocarcinoma (EXTEND): Results ...]
29. Research Conducted at Mercy Medical Center Has Provided New Information about Adenocarcinoma (Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix)
30. Fifteen-year outcomes of the ProtecT trial: Should patients be 'protected' from radical treatments?
31. Lapatinib Increases Overall Survival in Metastatic Breast Cancer Patients With HER2-Positive Circulating Tumor Cells
32. Findings from National University of Singapore Update Knowledge of Neuroendocrine Cancer [Peptide Receptor Radionuclide Therapy (Prrt) In Metastatic Neuroendocrine Tumors of Unknown Primary (Cup-nets)]
33. New Breast Cancer Study Findings Recently Were Reported by Researchers at University of California San Francisco (UCSF) [Overall Survival With Sacituzumab Govitecan In Hormone Receptor-positive and Human Epidermal Growth Factor Receptor ...]
34. Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients
35. A comparative study of whole brain radiotherapy with concomitant thalidomide versus whole brain radiotherapy alone in brain metastases
36. New Veterans Study Findings Have Been Reported by Investigators at St. Louis Veterans Affairs Medical Center (Survival of Veterans Treated With Enzalutamide and Abiraterone for Metastatic Castrate Resistant Prostate Cancer Based On Comorbid ...)
37. Department of Oncology Researcher Describes Research in Brain Metastasis (Survival of Patients with Metastatic Melanoma Treated with Ipilimumab after PD-1 Inhibitors: A Single-Center Real-World Study)
38. ERLEADA® apalutamide demonstrates statistically significant and clinically meaningful improvement in overall survival compared to enzalutamide in patients with metastatic castration-sensitive prostate cancer
39. Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
40. Patritumab Deruxtecan Demonstrated Statistically Significant Improvement in Progression-Free Survival Versus Doublet Chemotherapy in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer in HERTHENA-Lung02 Phase 3 Trial
41. BriaCell Quadruples Progression Free Survival (PFS) in Patient with 'Eye-Bulging' Metastatic Breast Cancer
42. Longitudinal survival trends of patients with cancer with surgically managed appendicular metastatic bone disease: systematic review
43. Investigators at Memorial Sloan-Kettering Cancer Center Detail Findings in Radiation Therapy (T1-weighted, Dynamic Contrast-enhanced Mr Perfusion Imaging Can Differentiate Between Treatment Success and Failure In Spine Metastases Undergoing ...)
44. New Robotics Findings from Charite University Hospital and School of Medicine Discussed (Robotic Stereotactic Body Radiotherapy for the Management of Adrenal Gland Metastases: a Bi-institutional Analysis)
45. Study Results from National University Cancer Institute in the Area of Chemotherapy Published (Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum-Based Chemotherapy Failure Setting)
46. New Data from Amsterdam University Medical Center Illuminate Research in Drugs and Therapies (Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?)
47. Studies from Institute of Quantitative Systems Pharmacology Describe New Findings in Ascites (Surgical Management of Peritoneal Metastasis: Opportunities for Pharmaceutical Research)
48. New Findings in Prostate Cancer Described from Dana-Farber Cancer Institute (Early Treatment Intensification In Metastatic Hormone-sensitive Prostate Cancer)
49. New Brain Metastasis Study Findings Have Been Reported by Researchers at Seoul National University [The Pattern of Care for Brain Metastasis From Breast Cancer Over the Past 10 Years In Korea: a Multicenter Retrospective Study (Krog 16-12)]
50. New Adenocarcinoma Research Has Been Reported by a Researcher at University of Florida College of Medicine (Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.